금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Latvia calls for visa ban on Russians
Prime Minister Andris Kulbergs links travellers to escalating hybrid threats from Moscow...
America’s $10tn AI infrastructure boom is starting to fray
A vast bet on the future of the technology is running into the unforgiving economics of the physical...
Europe must liberate Belgium from its huge Russian assets risk
What happens if the US tries to take control of the hundreds of billions blocked in Euroclear?...
UBS revamps S&P 500 target for rest of 2026
Stronger profits are changing the math for stocks again
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?
Here's how Invesco's concentrated pharma play compares to Fidelity's diversified approach to healthcare stocks.
SA Asks: Will Bessent's recent moves to curb bond yields boost the stock market?
'Spider-Man: Brand New Day' continues to dominate box office
Hedge funds and mutual funds split on the AI trade - Goldman
Warsh seeks to soothe investors’ nerves as signs of economic strain mount
Economists criticise Fed chair’s communication strategy as policymakers prepare to gather at Jackson Hole symposium
Yahoo, the internet’s ‘OG’, wants to win over Gen Z
Group’s chief says vintage web name can help draw younger users
Why every French politician is now a Gaullist
The revival of de Gaulle’s legendary role in the second world war coincides with an increasing number of claims to his legacy
Michael Burry dumps Alibaba for JD.com, says BABA would need to fall 50%
ATRenew reports another set of brilliant quarterly results
ATRenew (RERE) has just reported another set of excellent quarterly earnings. The company’s reported sales have turned out to be better than the sales reported for the same period a year ago and also ...
12 years trading Gold. What finally worked? [Video]
Meet Alan, a trader from South Africa with nearly 12 years of experience trading gold and indices. But his journey was not always profitable. After early failures, he rebuilt his confidence by scaling ...
NOVO_B price outlook: Novo Nordisk holds above 1 (100%) support ARC. Potential rebound toward 306.00
Overview: Based on Arc Cycle Analysis applied to the 30m chart, Novo Nordisk is interacting with the 1 (100%) Support Arc within the current Arc Cycle. Price is holding above this Support Arc, suggest ...